Prostate cancer (PCa) is one of the most common malignant tumors among men worldwide. Following androgen deprivation therapy ...
Thousands of men in England living with advanced prostate cancer are poised to benefit from a new life-extending drug, ...
Decades ago, doctors created a test to determine which breast cancer patients should receive hormone therapy. Now, ...
Prostate cancer is the second-most common cancer in men. A new study from Thomas Jefferson University uncovered a new ...
South Korea's Hyundai ADM Bio plans to launch global clinical trials of its new drug, Penetrium, for rheumatoid arthritis and ...
For more than 40 years, Florida Cancer Specialists & Research Institute (FCS) has embraced innovation to deliver world-class care and drive the dramatic transformation of oncology care through its ...
Researchers have identified a gene that plays a key role in prostate cancer cells that have transitioned to a more aggressive, treatment-resistant form. The gene can be indirectly targeted with an ...
A large team of researchers led by Wouter Karthaus, head of the Endocrine Therapy Resistance and Molecular Genetics Lab at EPFL, and Eneda Toska at Johns Hopkins University have identified the enzyme ...
Prostate-specific antigen (PSA) is a protein produced by both normal and cancerous cells in the prostate gland. It is primarily measured through a blood test, where normal levels are typically found ...
Thousands of men with incurable prostate cancer will be offered a lifeline after an about-turn on NHS treatment.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results